Cell line name |
BCH |
Accession |
CVCL_B7K8 |
Resource Identification Initiative |
To cite this cell line use: BCH (RRID:CVCL_B7K8) |
Comments |
Population: Caucasian; Austrian. Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV). Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. |
Sequence variations |
- Mutation; HGNC; HGNC:7067; CIITA; Simple; p.Glu381Ter (c.1141G>T) (G1256T); ClinVar=VCV000009541; Zygosity=Heterozygous (PubMed=9099848).
- Mutation; HGNC; HGNC:7067; CIITA; Simple; c.3317+1G>A (IVS18DS,G-A,+1) (del3349-3432); ClinVar=VCV000009542; Zygosity=Heterozygous (PubMed=9099848).
|
Disease |
Bare lymphocyte syndrome type 2 (NCIt: C171268) Immunodeficiency by defective expression of MHC class II (ORDO: Orphanet_572) |
Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
Sex of cell |
Male |
Age at sampling |
Children |
Category |
Transformed cell line |
Publications | PubMed=1852002; DOI=10.1073/pnas.88.10.4285; PMCID=PMC51643 Bernard Benichou, Jack Leonard Strominger; Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. Proc. Natl. Acad. Sci. U.S.A. 88:4285-4288(1991) PubMed=1864634; DOI=10.3109/08820139109050783 Josef W. Mannhalter, Hermann M. Wolf, Helmut Gadner, Martin Potschka, Martha Marianne Eibl; Cell-mediated immune functions in a patient with MHC class II deficiency. Immunol. Invest. 20:151-167(1991) PubMed=9099848; DOI=10.1007/s004390050403 Severine Bontron, Viktor Steimle, Catherine Ucla, Martha Marianne Eibl, Bernard Mach; Two novel mutations in the MHC class II transactivator CIITA in a second patient from MHC class II deficiency complementation group A. Hum. Genet. 99:541-546(1997) |
Cross-references |
Encyclopedic resources |
Wikidata; Q112929281
|
Entry history |
Entry creation | 23-Jun-2022 |
Last entry update | 19-Dec-2024 |
Version number | 5 |
---|